Bhindi B - Search Results

1

Adjuvant therapy for renal cell carcinoma: 2023 Canadian Kidney Cancer Forum consensus statement.

Lalani AA, Kapoor A, Basappa NS, Bhindi B, Bjarnason GA, Bosse D, Breau RH, Canil CM, Cardenas LM, Castonguay V, Chavez-Munoz C, Chu W, Dudani S, Graham J, Heng DYC, Kollmannsberger C, Lattouf JB, Morgan S, Reaume MN, Richard PO, Swaminath A, Tanguay S, Wood LA, Lavallée LT. Lalani AA, et al. Among authors: bhindi b. Can Urol Assoc J. 2023 May;17(5):E154-E163. doi: 10.5489/cuaj.8381. Can Urol Assoc J. 2023. PMID: 37185210 Free PMC article.

2

Reply from Authors re: Andrea Gallina, Alessandro Nini, Francesco Montorsi, Alberto Briganti. Metabolic Syndrome as a Marker for Prostate Cancer: Still a Work in Progress. Eur Urol 2015;67:71-2.

Bhindi B, Fleshner NE. Bhindi B, et al. Eur Urol. 2015 Jan;67(1):72-73. doi: 10.1016/j.eururo.2014.04.001. Epub 2014 Apr 13. Eur Urol. 2015. PMID: 29422402 No abstract available.

3

Impact of the U.S. Preventive Services Task Force recommendations against prostate specific antigen screening on prostate biopsy and cancer detection rates.

Bhindi B, Mamdani M, Kulkarni GS, Finelli A, Hamilton RJ, Trachtenberg J, Zlotta AR, Evans A, van der Kwast TH, Toi A, Fleshner NE. Bhindi B, et al. J Urol. 2015 May;193(5):1519-24. doi: 10.1016/j.juro.2014.11.096. Epub 2014 Dec 3. J Urol. 2015. PMID: 25481037

4

The impact of the use of aspirin and other nonsteroidal anti-inflammatory drugs on the risk of prostate cancer detection on biopsy.

Bhindi B, Margel D, Hamilton RJ, Fernandes KA, Trottier G, Hersey KM, Finelli A, Trachtenberg J, Zlotta A, Kulkarni GS, Toi A, Evans A, van der Kwast TH, Fleshner NE. Bhindi B, et al. Urology. 2014 Nov;84(5):1073-80. doi: 10.1016/j.urology.2014.05.071. Epub 2014 Oct 24. Urology. 2014. PMID: 25443907

5

Author Reply.

Bhindi B, Karnes RJ. Bhindi B, et al. Urology. 2017 Nov;109:152. doi: 10.1016/j.urology.2017.06.056. Epub 2017 Sep 21. Urology. 2017. PMID: 28943048 No abstract available.

6

Editorial Comment.

Bhindi B. Bhindi B. J Urol. 2018 Jan;199(1):87-88. doi: 10.1016/j.juro.2017.07.101. Epub 2017 Sep 28. J Urol. 2018. PMID: 28963873 No abstract available.

7

Reply to Georgios Papadopoulos, Charalampos Fragkoulis, and Konstantinos Ntoumas' Letter to the Editor re: Bimal Bhindi, Igor Frank, Ross J. Mason, et al. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017;72:660-4.

Bhindi B, Boorjian SA. Bhindi B, et al. Eur Urol. 2018 Mar;73(3):e53. doi: 10.1016/j.eururo.2017.11.037. Epub 2017 Dec 12. Eur Urol. 2018. PMID: 29246642 No abstract available.

8

Renal functional outcomes in patients undergoing percutaneous cryoablation or partial nephrectomy for a solitary renal mass.

Mason RJ, Atwell TD, Lohse C, Bhindi B, Weisbrod A, Boorjian SA, Leibovich BC, Schmit GD, Thompson RH. Mason RJ, et al. Among authors: bhindi b. BJU Int. 2017 Oct;120(4):544-549. doi: 10.1111/bju.13917. Epub 2017 Jun 19. BJU Int. 2017. PMID: 28548236

9

Obesity is associated with risk of progression for low-risk prostate cancers managed expectantly.

Bhindi B, Kulkarni GS, Finelli A, Alibhai SM, Hamilton RJ, Toi A, van der Kwast TH, Evans A, Hersey K, Jewett MA, Zlotta AR, Trachtenberg J, Fleshner NE. Bhindi B, et al. Eur Urol. 2014 Nov;66(5):841-8. doi: 10.1016/j.eururo.2014.06.005. Epub 2014 Jun 18. Eur Urol. 2014. PMID: 24954793

10

Editorial Comment.

Bhindi B. Bhindi B. J Urol. 2017 Nov;198(5):1052-1053. doi: 10.1016/j.juro.2017.05.093. Epub 2017 Aug 3. J Urol. 2017. PMID: 28780288 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page